2025-03-01
2024-05-19
| Summary | |
|---|---|
| Cancer Type | Liver Cancer |
| Grade | NA |
| Stage | NA |
| Ethnicity | Asian |
| Gender | F |
| Age | 29 |
| Pathology Diagnosis | Epithelioid malignant tumor, consider mixed liver cancer, hepatocellular carcinoma and adenocarcinoma of bile duct, lympha cells invade portal area with fibrous tissues hyperplasia, IHC results: AFP(-), HEPA(-), PDEC(part +), P48(-), CD34 (vessel +), CK19 (+), PERK(-), PAKT(-), PMEK1/2(-), CK7(+), CK20(part +), CEA(part +). |
| Biopsy Site | Liver |
| Treatment History | NA |
| Pathology QC | HCC (Pa, P3). |
| Special Features | Slow growth; HBV(-); FGFR2 fusion |
| Mouse Strain | Balb/c nu |
| TMA | NA |
| Viral Status in PDX | HBV-, HCV-, HIV- (P3, RNAseq) |
| Available In | CB_CN |
| RNA Seq | P3 |
| Exome Seq | NA |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy